Elazzouzi Amy
SVP, Finance & PAO
Elazzouzi Amy has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Elazzouzi Amy is listed as Senior Vice President, Finance at Aura Biosciences, Inc. Inside the rolling window, Elazzouzi Amy reported no open-market purchases and 3 open-market sales totaling $57K in AURA. The largest disclosed transaction in the window is a sale of 8,549 AURA shares on Feb 17, 2026, worth $43K.
Companies traded
Other insiders at AURA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$57K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Elazzouzi Amy made?
Elazzouzi Amy has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Elazzouzi Amy trade?
Elazzouzi Amy has filed SEC Form 4 disclosures for 1 company, including AURA.
When was Elazzouzi Amy's most recent SEC Form 4 filing?
Elazzouzi Amy's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Elazzouzi Amy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Elazzouzi Amy is listed as SVP, Finance & PAO.
What is Elazzouzi Amy's total buy and sell value in the current window?
Inside the rolling retention window, Elazzouzi Amy bought $0 and sold $57K based on SEC Form 4 filings.
What was Elazzouzi Amy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,549 AURA shares on 2026-02-17, worth $43K, per SEC Form 4 filings.